An archive of public press-releases announcing important events at CDI Laboratories.

APRIL 2017 – CDI LABORATORIES AND NEOBIOTECHNOLOGIES FORM ALLIANCE TO DISTRIBUTE CDI’S 2500 MONOSPECIFIC TRANSCRIPTION FACTOR ANTIBODIES

MAY 2017 – CDI LABS EXPANDS HUPROT™ – THE HIGHEST CONTENT HUMAN PROTEOME MICROARRAY IN THE WORLD

NOVEMBER 2017 – THE WORLD’S LARGEST HUMAN PROTEOME MICROARRAY: ADVANCING PROTEIN BIOMARKER DISCOVERY

NOVEMBER 2017 – CDI LABS CITES NEW RESEARCH IDENTIFYING EARLY LUNG CANCER AUTOANTIBODY BIOMARKERS USING HUPROT™

MARCH 2018 – CDI LABS COLLABORATES ON DISCOVERY OF NEW BIOMARKERS FOR ZIKA INFECTION

MARCH 2018 – CDI LABS’ MONOCLONAL ANTIBODY DEVELOPMENT PIPELINE FEATURED IN NATURE METHODS

APRIL 2018 – CDI LABORATORIES INC. OPENS $17M BIOTECH LAB IN MAYAGÜEZ

MARCH 2019 – CDI LABS RELEASES HUPROT™ V4.0 – ADDING ADDITIONAL CONTENT TO LARGEST CONTENT HUMAN PROTEOME MICROARRAY IN THE WORLD

MARCH 2019 – CDI LABS TO SHOWCASE IMMUNO-ONCOLOGY PRODUCTS & SERVICES AT AACR 2019

FEBRUARY 2020 – CDI LABS LAUNCHES TWO NEW POWERFUL ASSAYS TO ITS BIOMARKER DISCOVERY PLATFORM

SEPTEMBER 2020 – CDI LABS HUPROT™ PROTEIN ARRAYS INSTRUMENTAL IN RECENT STUDY OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C)

JANUARY 2023 – BROADOAK CAPITAL PARTNERS INVESTS IN CDI LABORATORIES TO EXPAND AND SCALE ANTIBODY BIOMARKER DISCOVERY PLATFORMS

AUGUST 2023 – BARNEY E. SAUNDERS PH.D. HAS BEEN APPOINTED CHIEF EXECUTIVE OFFICER OF CDI LABORATORIES.